Connect with us


Cannabidiol (CBD) Market Estimated Forecast Analysis 2019-2025

Republished by Plato



This intensively research documentation articulating relevant details about growth initiators of the Cannabidiol (CBD) market has been designed to equip report readers and aspiring market participants with high end reference material to gauge into the nitty gritty of developments, events, trends as well as challenges and threats that influence growth prognosis in the global Cannabidiol (CBD) market.

An easy ready-to-refer guide to comprehend the market scenario and growth prospects have been highlighted and discussed in detail and enlisted as effective points in the following sections of this elaborate research report on Cannabidiol (CBD) market.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @

The study encompasses profiles of major companies operating in the Cannabidiol (CBD) Market. Key players profiled in the report includes:

The following manufacturers are covered:
Pure Technologies
Gassonic A/S
F.A.S.T. GmbH
GfG – Gesellschaft fr Gertebau
Hermann Sewerin GmbH
Labthink Instruments Co., Ltd.
New Cosmos
Diakont Advanced Tehnologies
Schneider Electric
FMC Technologies
OMEGA Engineering

Segment by Regions
North America

Segment by Type
Pressure Measurement
Flow Measurement

Segment by Application
Oil & Gas Pipelines
Water and Wastewater Water Mains

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [email protected] 

Additionally, the report serves as a convenient guide to design and implement potential growth steering activities across select regional pockets in the Cannabidiol (CBD) market. Frontline players and their effective growth strategies are also enlisted in the report to emulate growth.

The report also is a collective hub to identify both upstream and downstream market developments and events comprising raw material sourcing as well as downstream demand prospects that harness an agile growth prognosis in the Cannabidiol (CBD) market.

A critical evaluation of market segmentation reveals that Cannabidiol (CBD) market is systematically classified into type and application

Analysis by Type: This section of the report includes factual details pertaining to the most lucrative segment harnessing revenue maximization.

Analysis by Application: Further in the subsequent sections of the report, research analysts have rendered precise judgement regarding the various applications that the Cannabidiol (CBD) market mediates for superlative end-user benefits.

You can Buy This Report from Here @ 

The Overall Unraveling Of The Cannabidiol (CBD) Market Is As Per The Following Determinants:

  • This report aims to holistically characterize and classify the Cannabidiol (CBD) market for superlative reader understanding
  • The report surveys and makes optimum forecast pertaining to market volume and value estimation
  • A thorough evaluation to investigate material sources and downstream purchase developments are echoed in the report
  • Elaborate references on purchaser needs, barrier analysis and opportunity assessment are also ingrained 

Decoding Regional Overview of the Cannabidiol (CBD) Market

Further in its subsequent sections of the report, this mindful presentation of the Cannabidiol (CBD) market lends vital details on regional scope and development sprees highlighting potential growth spots.

– North America (U.S., Canada, Mexico)

– Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

– Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

– Latin America (Brazil, Rest of L.A.)

– Middle East and Africa (Turkey, GCC, Rest of Middle East)

These details are indicated in the report to allow market players undertake a systematic analytical review of the Cannabidiol (CBD) market to arrive at logical conclusions governing the growth trajectory of the Cannabidiol (CBD) market and their subsequent implications on the growth of the aforementioned market.

Some Major TOC Points:

Chapter 1. Report Overview

Chapter 2. Global Growth Trends

Chapter 3. Market Share by Key Players

Chapter 4. Breakdown Data by Type and Application

Chapter 5. Market by End Users/Application

Chapter 6. COVID-19 Outbreak: Cannabidiol (CBD) Industry Impact

Chapter 7. Opportunity Analysis in Covid-19 Crisis

Chapter 9. Market Driving Force

And Many More…

Global Cannabidiol (CBD) Market Report: Research Methodology

What To Expect From The Report

  • A complete analysis of the Cannabidiol (CBD) market
  • Concrete and tangible alterations in market dynamics
  • A thorough study of dynamic segmentation of the Cannabidiol (CBD) market
  • A complete review of historical, current as well as potential foreseeable growth projections concerning volume and value
  • A holistic review of the vital market alterations and developments
  • Notable growth friendly activities of leading players

For More Information Kindly Contact:


Mr. Rohit Bhisey,

90 State Street,

Albany NY,

United States – 12207

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [email protected]



Dosage for CBG/CBD tincture from LN?

Republished by Plato



I just ordered the 1:1 CBG/CBD tincture from L. Naturals since I’ve heard CBG does wonders to anxiety, but since I am taking CBD now I didn’t want to go “cold turkey” off CBD and switch to CBG isolate (without knowing how well CBG works, plus full-spectrum/entourage effect).

Right now I am taking 25mg three times a day (1.25ml or 0.50ml three times of the high-potency tincture). What should I start with? I know really I should start low and increase, but like I said I don’t want to quit taking CBD while doing this process even though I know I should be good for a couple of days not taking my daily doses. Also, I’m on a lot of prescriptions right now that aren’t being affected, or noticeably affected, by CBD. Will CBG differ, especially with benzos/SSRI’s?


Continue Reading


Indus Holdings, Inc. Welcomes Bruce Gates to Board of Directors; Announces Results of Annual Shareholder Meeting

California cannabis industry leader adds veteran executive and strategic advisor to leadership team SALINAS, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) — Indus Holdings, Inc. (CSE: INDS; OTCQX: INDXF), a leading, vertically-integrated cannabis company (the “Company”), is pleased to announce that at its annual shareholder meeting held on October 22, 2020 (the “Meeting”) shareholders voted in […]

Republished by Plato



California cannabis industry leader adds veteran executive and strategic advisor to leadership team

SALINAS, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) — Indus Holdings, Inc. (CSE: INDS; OTCQX: INDXF), a leading, vertically-integrated cannabis company (the “Company”), is pleased to announce that at its annual shareholder meeting held on October 22, 2020 (the “Meeting”) shareholders voted in excess of 99% in favour of election of the Company’s nominees to the Board of Directors and the appointment of the Company’s auditors. At the Meeting, shareholders elected each of the incumbent directors of the Company nominated, in addition to new Company nominee Bruce A. Gates, a veteran executive and strategic advisor.

Mr. Gates serves as the Founder and President of Three Oaks Strategies LLC, a Virginia-based consulting firm that advises companies and individuals on strategic communications matters and public policy. He is also Founder and President of Three Oaks Asset Management LLC, a family office and venture capital firm that works to augment its financial participation with management advice, marketing advice, and relationship-building advice.

Bruce Gates is a seasoned executive with immense experience within complex regulatory environments set against shifting political backdrops.

Indus Holdings, Inc. Chairman of the Board George Allen

We are incredibly fortunate to have a leader and strategist of Bruce’s caliber on our board as we work to continue to take Indus to new heights of success.

Mr. Gates has served as Senior Vice President of External Affairs for Altria and briefly served as Altria’s representative on the board of Chronos Inc. He was a founding partner of Washington, D.C. public policy advocacy firm Washington Council, which was acquired by Ernst & Young in 2000.

“While it is still a young company, Indus has set the standard for a vertically-integrated cannabis operation with its acclaimed brand portfolio and commitment to being compliant in a highly regulated industry,” Mr. Gates says. “I am very grateful for the opportunity to lend my expertise to the board and I look forward to even greater success for Indus.”

Mr. Gates’ election comes as Indus Holdings, Inc. Co-Founder Robert Weakley departs the Board of Directors.

“We would like to thank Robert for all his service and his immense contributions to this Company as its co-founder. It is not easy for a founder to leave a company that he/she started and Rob has done an exemplary job and made every effort to make the transition as successful as possible. We are very grateful for Robert,” Mr. Allen says.

With Mr. Gates’ election, the following individuals now serve on the Board of Directors: George Allen (Chairman), Mark Ainsworth (Chief Executive Officer), Stephanie Harkness, William Anton, Kevin McGrath, Brian Shure and Bruce Gates.

In connection with the Meeting, the Company delivered a management information circular dated September 22, 2020 to its shareholders and filed the same on SEDAR. Prior to the filing thereof, the Company relied on the temporary blanket relief provided by the Canadian Securities Administrators, including the exemptive relief contained in Ontario Instrument 51-504 – Temporary Exemptions from Certain Requirements to File or Send Securityholder Materials of the Ontario Securities Commission, to postpone the public filing of its executive compensation disclosure required under National Instrument 51-102 – Continuous Disclosure Obligations in respect of the Company’s financial year ended December 31, 2019.

Indus Holdings, Inc. (CSE: INDS; OTCQX: INDXF) is a vertically-integrated cannabis company with advanced production capabilities, including cultivation, extraction, manufacturing, brand sales & marketing, and distribution. Founded in 2014 and based in Salinas, California, Indus offers services supporting every step of the supply chain and an extensive portfolio of award-winning brands, including Cypress Cannabis, House Weed, The Original Pot Co., MOON, Humble Flower, and Kaizen Medicinals. Indus Distribution, a division of Indus Holdings, Inc., is a leading California distributor of cannabis products, servicing an extensive portfolio of brands and licensed retailers.

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter


Continue Reading


Leading Colorado Edibles Brand Sees This Product as The Future of Cannabis Consumption

Exclusive Interview with 1906 Co-Founder and CEO Peter Barsoom Since launching in 2017, edibles company 1906 has been focused on creating a new product category: functional cannabis. It sees the opportunity to offer high-functioning adults an alternative to alcohol and pharmaceuticals as they navigate daily life, according to Co-Founder and CEO Peter Barsoom. Barsoom last […]

Republished by Plato



Exclusive Interview with 1906 Co-Founder and CEO Peter Barsoom

Since launching in 2017, edibles company 1906 has been focused on creating a new product category: functional cannabis. It sees the opportunity to offer high-functioning adults an alternative to alcohol and pharmaceuticals as they navigate daily life, according to Co-Founder and CEO Peter Barsoom. Barsoom last spoke with New Cannabis Ventures in April 2019, and he checked in to discuss an innovative new product, new markets and continued expansion. The audio of the entire conversation is available at the end of this written summary.

New Team Members

Over the past year and a half, 1906 has made some additions to its leadership team. Jackie Cornell has taken on the role of Chief of Policy and Health Innovation. She has a long career in public health, previously working for the New Jersey Department of Health where she helped regulate the state’s medical market.

Chonie Bradley joined 1906 as Vice President of Finance. She previously served as the Vice President of Finance with Anne Holland Ventures, the company behind MJBizCon.

Market Reach and Expansion Philosophy

1906 currently has a presence in Colorado and Oklahoma. Within the next couple of weeks, it will be launching into Illinois and Massachusetts as well.

Inside 1906’s Operations (Photo Taken Prior to the COVID-19 Pandemic)

The company is working toward becoming the top brand east of the Rockies, according to Barsoom. When considering potential markets, the 1906 team likes limited-license markets–medical, adult-use or about to become adult-use. States like Illinois, Massachusetts, Maryland, Pennsylvania and New Jersey are appealing. But, the company finds markets with low barriers to entry interesting as well. It has built success in markets like that with its Colorado and Oklahoma operations.

1906 expects to be in four markets by the end of this year, and it plans to launch in three or four new markets next year.

The company’s growth this year has had to take place during the COVID-19 pandemic, which has driven the company to embrace an agile and lean strategy. With such a capital-tight market, 1906 is approaching expansion into new markets with a capital-light mindset. It is reaching new markets through partnerships, but it is taking a unique approach.

Instead of developing traditional licensing agreements, 1906 has created a mobile tableting operation. Through this initiative, a truck contains all the necessary equipment to create the company’s Drops. 1906 establishes a relationship with a local operator, taking up less than 750 square feet in their facility. Within just a few weeks, the operation can produce 3 to 5 million tablets of the 1906 Drops, according to Barsoom.

The mobile tableting operations allow 1906 to expand into new markets with a consistent set of equipment and without a significant capital investment. It is able to retain ownership and control of its manufacturing processes and intellectual property. The company is able to capture 50 percent of wholesale revenue through its partnership deals, according to Barsoom.

Product Portfolio

1906 views its competition through a lens wider than just the cannabis industry. Products that people use to manage and enjoy their lives, whether it is a cup of coffee, a glass of wine or a sleep aid, are competition for 1906’s products.

The company’s products, divided into different effects, are made with a combination of cannabinoids and other plant medicines. At the beginning of this year, 1906 launched its Genius effect, designed for cognitive focus. This product has a personal meaning for Barsoom. Diagnosed with ADD as a teenager, he has used Ritalin and Adderall for most of his adult life. While those medications worked for him, there are side effects. He hopes Genius can provide a potential alternative for cognitive focus. Already, Genius has become a top-selling product in Oklahoma, according to Barsoom.

The Genius Effect Has Been Developed to Support Cognitive Focus.

1906 has also launched its line of pressed tablets: Drops. These swallowable pills offer a way to experience cannabis in a traditional medicinal format. The Drops, available in any of 1906’s different effects, are controlled-dose, allergen-free and calorie-free. Barsoom sees this as becoming the future of cannabis consumption.

The Development and Launch of 1906 Drops Has Been a Major Focus for the Company Over the Past Year.

Previously, 1906 was excited about beverages, but now, the company has stepped back from this product category. Barsoom still sees opportunity in the long-term, but he thinks that social consumption will need to take off first.

While beverages are on the backburner, 1906 has a robust innovation pipeline. The company is working on extended-release tablets for its Midnight effect. Sleep is a major issue for millions of people, and 1906 sees an underserved segment in that market: people who don’t have trouble falling asleep but struggle to stay asleep. This new product will target those people.

1906’s Midnight Effect Features Chocolates Designed to Support Sleep. (Photo Taken Prior to the COVID-19 Pandemic)

1906 is also developing products to address women’s health and different types of pain.

Funding Insight

1906 raised $18 million last fall, and now, the company is in the process of raising a bridge round. This senior secured debt note, which is mostly funded, will help provide the necessary capital to reach profitability, according to Barsoom. The company expects to hit this milestone by December. After that, funding will become driven more by opportunity.

When allocating capital, 1906 carefully considers R&D projects as well as new market expansion.

In terms of future capital opportunities, Barsoom is carefully watching the opportunities that are currently on the sidelines. The outcome of the 2020 election could mean an influx of new, large institutional players into the market. Additionally, Barsoom is watching to see how SPAC money will be chasing deals in the industry.

Growth Outlook

In its first month of operations in Oklahoma, 1906 exceeded revenue expectations by three to four times, and Barsoom expects this trend to continue. Once the company reaches profitability in December, he anticipates the company will generate significant operating cash flow. As the company moves forward, its team tracks important metrics like same-store sales, labor productivity and return on investment capital.

While 1906 is highly focused on its innovation pipeline and expansion into new markets, the company is not losing sight of its responsibility to social justice. 1906 supports initiatives like the Last Prisoner Project and advocates for the creation of economic opportunities for people affected by the War on Drugs and for the end of mass incarceration. Barsoom sees the potential for cannabis to be a positive force in society, but he thinks the industry has not yet done enough to support and progress social justice issues.

New Cannabis Ventures provides a customized landing page for 1906, which is a client of New Cannabis Ventures. Listen to the entire interview:

Carrie Pallardy, a Chicago-based writer and editor, began her career covering the healthcare industry and now writes, edits and interviews subject matter experts across multiple industries. As a published writer, Carrie continues to tell compelling, undiscovered stories to her network of readers. For more information contact us.

Get Our Sunday Newsletter


Continue Reading
Heartland2 days ago

Web site credit card processing

Heartland1 day ago

CBG Study Shows Antimicrobial Properties of Cannabis

Heartland1 day ago

Medical Marijuana: 7 Incredible Health Benefits for Women

Heartland5 days ago

CBD Flower vs Vaping

Heartland13 hours ago

German Cannabis Flower Market is Ready to Explode

Heartland5 days ago

CBD weed in the U.K.

Heartland4 days ago

Best cbd oil uk

Heartland5 days ago

Giveaway for CBD Gummies on Instagram

Heartland4 days ago

Interesting effects from full spectrum

Heartland4 days ago

Awful taste – Lazarus Naturals. Is there flavored version better ?

Heartland4 days ago

Anyone else find Dosist pens wonky?

Heartland4 days ago

What type of hemp products do you use?

Heartland4 days ago


CBD3 days ago

CBD and Geriatric Medicine: Should Seniors Take CBD?

Heartland3 days ago

CBG tinctures

Heartland5 days ago

Oof- CBD flower experience gone bad..

Heartland5 days ago

Has anyone ever tired any products from, “”? Wanting to try the CBD:CBG vape.

Heartland4 days ago

The Hemp Store Strategizes Wholesale Agreement With Maine Coast Hemp

Heartland3 days ago

Best CBD topical for Trigger Points?

Heartland4 days ago

Making cbd/cbg tinture

Heartland4 days ago

Review of several products from GreatCBDShop

Heartland3 days ago

CBD for anxiety/sleep

CBD3 days ago

CBD News: Hemp Industry Daily launches annual industry survey for business data

Heartland3 days ago

CBD & Cannabis for Endometriosis

Heartland3 days ago

Where do I start for depression?

Heartland2 days ago

Find your perfect sleep system

Heartland1 day ago

Thanks to these CBD “cigarettes” I am a full week tobacco/nicotine free 🎉

Heartland10 hours ago

Cybin Raises C$45 Million: The Largest Go Public Capital Raise in the Canadian Psychedelic Sector

Heartland5 days ago

Seven charged, 26 infringements issued during operation targeting anti-social behaviour …

Heartland5 days ago

First time vaping CBD for anxiety


A Cloud Nine Capital Entity Copyright © 2020 – All Rights Reserved Proudly Made in America